Celltrion Healthcare Australia Pty Ltd
Regulatory activities for this sponsor.
Loading...
Sponsor content
53 result(s) found, displaying 1 to 10
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for OMLYCLO omalizumab (rch) 75 mg/0.5 mL solution for injection in a pre-filled syringe with needle guard.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for OMLYCLO omalizumab (rch) 150 mg/ mL solution for injection in a pre-filled syringe with needle guard.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for YUFLYMA adalimumab (rch) 20 mg/0.2 mL solution for injection pre-filled syringe.
-
Prescription medicine registrationActive ingredients: Omalizumab.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for STEQEYMA ustekinumab 90mg/1 mL solution for injection pre-filled syringe with safety guard.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for STEQEYMA ustekinumab 130 mg/26 mL concentrate for solution for infusion vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for STEQEYMA ustekinumab 45 mg/0.5 mL solution for injection pre-filled syringe with safety guard.
-
Prescription medicine decision summarySteqeyma (ustekinumab) has been approved to treat moderate to severe plaque psoriasis, active psoriatic arthritis, crohn's disease, and ulcerative colitis
-
Prescription medicine registrationActive ingredients: Ustekinumab.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for VEGZELMA bevacizumab 400 mg/ 16 mL solution for intravenous infusion, vial.